Mitchell MS - Search Results

1

A novel melanoma gene (MG50) encoding the interleukin 1 receptor antagonist and six epitopes recognized by human cytolytic T lymphocytes.

Mitchell MS, Kan-Mitchell J, Minev B, Edman C, Deans RJ. Mitchell MS, et al. Cancer Res. 2000 Nov 15;60(22):6448-56. Cancer Res. 2000. PMID: 11103812

2

Phase I trial of large multivalent immunogen derived from melanoma lysates in patients with disseminated melanoma.

Mitchell MS, Kan-Mitchell J, Morrow PR, Darrah D, Jones VE, Mescher MF. Mitchell MS, et al. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):76-83. doi: 10.1158/1078-0432.ccr-0689-3. Clin Cancer Res. 2004. PMID: 14734454 Clinical Trial.

3

Tumor-reactive human immunoglobulin G monoclonal antibody from a melanoma patient.

Kan-Mitchell J, White WL, Mitchell MS. Kan-Mitchell J, et al. Among authors: mitchell ms. Cancer Res. 1989 Aug 15;49(16):4536-41. Cancer Res. 1989. PMID: 2472881

4

Novel gene sequences expressed by human melanoma cells identified by molecular subtraction.

Hutchins JT, Deans RJ, Mitchell MS, Uchiyama C, Kan-Mitchell J. Hutchins JT, et al. Among authors: mitchell ms. Cancer Res. 1991 Mar 1;51(5):1418-25. Cancer Res. 1991. PMID: 1997180

5

Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope.

Mitchell MS, Darrah D, Yeung D, Halpern S, Wallace A, Voland J, Jones V, Kan-Mitchell J. Mitchell MS, et al. J Clin Oncol. 2002 Feb 15;20(4):1075-86. doi: 10.1200/JCO.2002.20.4.1075. J Clin Oncol. 2002. PMID: 11844833 Clinical Trial.

6

Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant.

Mitchell MS, Kan-Mitchell J, Kempf RA, Harel W, Shau HY, Lind S. Mitchell MS, et al. Cancer Res. 1988 Oct 15;48(20):5883-93. Cancer Res. 1988. PMID: 3262416

7

Human monoclonal antibodies directed against melanoma tumor-associated antigens.

Kan-Mitchell J, Imam A, Kempf RA, Taylor CR, Mitchell MS. Kan-Mitchell J, et al. Among authors: mitchell ms. Cancer Res. 1986 May;46(5):2490-6. Cancer Res. 1986. PMID: 3697990

8

Assignment of a human melanoma associated gene MG50 (D2S448) to chromosome 2p25.3 by fluorescence in situ hybridization.

Weiler SR, Taylor SM, Deans RJ, Kan-Mitchell J, Mitchell MS, Trent JM. Weiler SR, et al. Among authors: mitchell ms. Genomics. 1994 Jul 1;22(1):243-4. doi: 10.1006/geno.1994.1374. Genomics. 1994. PMID: 7959781 Free article. No abstract available.

9

Detection of melanoma-reactive CD4+ HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-gamma.

LeMay LG, Kan-Mitchell J, Goedegebuure P, Harel W, Mitchell MS. LeMay LG, et al. Among authors: mitchell ms. Cancer Immunol Immunother. 1993 Aug;37(3):187-94. doi: 10.1007/BF01525434. Cancer Immunol Immunother. 1993. PMID: 8101473 Free PMC article.

10

Non-fastidious, melanoma-specific CD8+ cytotoxic T lymphocytes from choroidal melanoma patients.

Huang XQ, Mitchell MS, Liggett PE, Murphree AL, Kan-Mitchell J. Huang XQ, et al. Among authors: mitchell ms. Cancer Immunol Immunother. 1994 Jun;38(6):399-405. doi: 10.1007/BF01517210. Cancer Immunol Immunother. 1994. PMID: 8205561 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters